Inbios Internationalincis A Biotechnology Company Based In Seattleestablished In 1996The Company Specializes In Infectious Disease Diagnostics And Contract Manufacturingfocusing On Developing Immunodiagnostic Assaysinbios Is Recognized For Its Expertise In Antibody And Antigen Researchand It Has Shown Adaptability In Addressing Global Health Challengesincluding Zikawest Nile Virusand Covid 19 The Company Offers Full Service Contract Manufacturing With Cgmp Standards And Iso 13485 Certificationits Diagnostic Development Capabilities Span From Protein Purification To Commercializationutilizing Machine Learning For Test Optimizationinbios Produces Rapid Diagnostic Testsincluding Elisa Based And Lateral Flow Assays For Various Infectious Diseasesnotable Products Include Fda Authorized Tests For Zika Virus And Covid 19As Well As Participation In The Lymex Diagnostics Prize For Lyme Disease Diagnosticsinbios Collaborates With Government Initiatives To Enhance Diagnostic Innovation And Supports Medical Device Developers With Compliant Manufacturing Services
